Nausheen Ahmed, MD, on the Impact of Prior Treatments on the Safety of Brexu-cel
June 13th 2023The assistant professor in the Division of Hematologic Malignancies and Cellular Therapeutics at the University of Kansas Medical Center discussed real-world safety outcomes for brexu-cel in patients with r/r MCL.